Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer

Table 3 Disability weights for each disease state according to cancer site

Cancer sites	Disease states
Cancer sites	Diagnosis & initial treatment	Control	Pre-terminal	Terminal
Lip oral cavity	0.56	0.37	0.90	0.93
Nasopharynx	0.56	0.37	0.90	0.93
Other pharynx	0.56	0.37	0.90	0.93
Oesophagus	0.56	0.37	0.93	0.93
Stomach	0.53	0.38	0.93	0.93
Colorectum	0.43	0.20	0.83	0.93
Liver	0.43	0.20	0.83	0.93
Gallbladder	0.43	0.20	0.83	0.93
Pancreas	0.43	0.20	0.83	0.93
Larynx	0.56	0.37	0.90	0.93
Lung	0.72	0.47	0.91	0.93
Melanoma of skin	0.26	0.19	0.81	0.93
Kaposi Sarcoma	0.51	0.14	0.83	0.93
Breast	0.54	0.26	0.79	0.93
Cervix uteri	0.43	0.20	0.75	0.93
Corpus uteri	0.43	0.20	0.75	0.93
Ovary	0.43	0.20	0.75	0.93
Prostate	0.27	0.18	0.64	0.93
Testis	0.27	0.18	0.64	0.93
Kidney	0.27	0.18	0.64	0.93
Bladder	0.27	0.18	0.64	0.93
Brain, nervous system	0.68	0.18	0.75	0.93
Thyroid	0.27	0.18	0.64	0.93
Hodgkin lymphoma	0.55	0.19	0.75	0.93
Non-Hodgkin lymphoma	0.55	0.19	0.75	0.93
Multiple myeloma	0.19	0.19	0.75	0.93
Leukaemia	0.55	0.19	0.75	0.93

Data source: Dutch and Victorian burden of disease study and the Global Burden of Disease project [3, 5, 6].
Estimates applied to all countries.

ISSN: 1471-2288